Cochlear Implantation in Autoimmune Inner‐Ear Disease: Outcome and Patient‐Reported Benefit
The Laryngoscope · 2026-09 · 136 (9) · 3980-3989
DOI: 10.1002/lary.70548 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 07.04.2026. Verfasst von Merete Hartmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Cochlear Implantation, Hearing Loss, Sensorineural, Autoimmune Inner Ear Disease, Patient Reported Outcome Measures. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate cochlear implant (CI) outcomes in patients with hearing loss related to secondary autoimmune inner ear disease (AIED) compared to a matched control cohort. Patients and Methods In this retrospective cohort study, we included seven patients with profound sensorineural hearing loss (SNHL) related to secondary AIED treated with a CI. Data on pre‐ and postoperative pure‐tone audiometry, speech perception in quiet and noise (German Freiburg mono‐ and multisyllable test, Oldenburg sentence test), and patient‐reported outcome measures (Speech, Spatial, and Qualities of Hearing Scale, SSQ12) were assessed and compared to a matched control cohort.
Results
Postoperative recognition of monosyllables (65 dB SPL ) in AIED patients and controls showed significant improvement ( p < 0.0001) after 12 months with gains of 54 and 58 percentage points, respectively. However, AIED patients required a substantially higher signal to achieve 50%‐word recognition in sentence testing in noise compared to controls. Notably, subjective hearing abilities tested in the SSQ12 in both groups improved substantially, reaching 4.4 [2.4–6.5] in the AIED group and 5.1 [4.5–5.8] in controls at 12 months, showing a convergence of scores compared to the preoperative group difference.
Conclusion
AIED patients substantially benefit from cochlear implantation despite potentially ongoing chronic inner‐ear inflammation. In contrast to poorer performance in classical audiological test settings such as monosyllable presentation and word recognition in noise, self‐perceived hearing was reported nearly as favorable as in the control cohort. Timely diagnosis, tailored preoperative imaging, and individualized rehabilitation are key to improved CI performance in AIED patients. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Göttingen, Göttingen, Germany.
ORCID-Profile: Christian Wrobel
Zitieren
APA
Hartmann, M., Oestreicher, D., Hüser, M. A., Beutner, D., & Wrobel, C. (2026). Cochlear Implantation in Autoimmune Inner‐Ear Disease: Outcome and Patient‐Reported Benefit. The Laryngoscope, 136(9), 3980-3989. https://doi.org/10.1002/lary.70548
Vancouver
Hartmann M, Oestreicher D, Hüser MA, Beutner D, Wrobel C. Cochlear Implantation in Autoimmune Inner‐Ear Disease: Outcome and Patient‐Reported Benefit. The Laryngoscope. 2026;136(9):3980-3989. doi:10.1002/lary.70548
BibTeX
@article{Hartmann2026,
author = {Hartmann, Merete and Oestreicher, David and Hüser, Marc Albert and Beutner, Dirk and Wrobel, Christian},
title = {Cochlear Implantation in Autoimmune Inner‐Ear Disease: Outcome and Patient‐Reported Benefit},
journal = {The Laryngoscope},
year = {2026},
volume = {136},
number = {9},
pages = {3980--3989},
doi = {10.1002/lary.70548}
}
EUVIMED